Showing results (1591-1600 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 17, 2008
Response assessment in clinical trials: implications for sarcoma clinical trial designC Carl Jaffe
The Oncologist|June 17, 2008
Endpoints for assessing drug activity in clinical trialsRichard Pazdur
The Oncologist|April 2, 2008
Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?Mateya Trinkaus, Sheray Chin, Wendy Wolfman, et al.
The Oncologist|April 2, 2008
The clinical approach towards chondrosarcomaHans Gelderblom, Pancras C W Hogendoorn, Sander D Dijkstra, et al.
The Oncologist|April 9, 2025
Treatment delays in patients with lung cancer: a retrospective study conducted at the National Cancer Institute of Mexico between 2004 and 2021Elysse Bautista-González, Teresa Verenice Muñoz Rocha, Enrique Soto-Perez-de-Celis, et al.
The Oncologist|April 4, 2025
Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studiesSara Lopez-Tarruella, Marina Pollán, Eva Carrasco, et al.
The Oncologist|April 4, 2025
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitorsPaulo S do Amaral, Kathryn E Beckermann, Jennifer B Gordetsky, et al.
The Oncologist|April 24, 2025
Tumor-infiltrating lymphocytes as predictive biomarkers in neoadjuvant treatment of HER2-positive breast cancerOğuzcan Kınıkoğlu, Yunus Emre Altıntaş, Anıl Yıldız, et al.
The Oncologist|April 22, 2025
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumorsNai-Jung Chiang, Jih-Hsiang Lee, Ming-Huang Chen, et al.
The Oncologist|April 22, 2025
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomesYasaman Iranmanesh, Noha Omar, Arya Rasouli, et al.
Pageof 571